Javascript must be enabled to continue!
Interaction Between Coxsackievirus B3 Infection and α-Synuclein in Parkinson’s Disease
View through CrossRef
Abstract
BackgroundParkinson's disease (PD) is one of the most common neurodegenerative disease. PD is pathologically characterized by the death of midbrain dopaminergic neurons and the accumulation of intracellular protein inclusions called Lewy bodies or Lewy neurites. The major component of Lewy bodies is α-synuclein (α-syn). Prion-like propagation of α-syn has emerged as a novel mechanism in the progression of PD. Targeting this mechanism could enable the development of disease-modifying therapies for patients with PD. Nevertheless, the initial triggers of LB formation leading to acceleration of the process remain elusive.MethodsTo evaluate α-syn function in viral replication, we infected coxsackievirus B3 (CVB3) to α-syn overexpressed neurons or α-syn transgenic (TG) mice. We then performed biochemical and histological analyses to evaluate interaction between CVB3 and α-syn in Lewy body formation.ResultsWe demonstrated that CVB3 infection can induce α-syn-associated inclusion body formation in neurons as a trigger. The inclusion bodies contained clustered organelles, including damaged mitochondria with α-syn fibrils. α-Syn overexpression accelerated inclusion body formation and induced more concentric inclusion bodies. In brains from CVB3 infected mice, α-syn aggregates in the cell body of midbrain neurons were observed. Additionally, α-syn overexpression favored CVB3 replication and related cytotoxicity. α-Syn transgenic mice had a low survival rate, enhanced CVB3 replication, and further neuronal cell death, including dopaminergic neurons in the substantia nigra. These results may be due to the different usage of autophagy between CVB3 and α-syn. ConclusionsThis study elucidated the mechanism of Lewy body formation and the pathogenesis of PD associated with CVB3 infection.
Title: Interaction Between Coxsackievirus B3 Infection and α-Synuclein in Parkinson’s Disease
Description:
Abstract
BackgroundParkinson's disease (PD) is one of the most common neurodegenerative disease.
PD is pathologically characterized by the death of midbrain dopaminergic neurons and the accumulation of intracellular protein inclusions called Lewy bodies or Lewy neurites.
The major component of Lewy bodies is α-synuclein (α-syn).
Prion-like propagation of α-syn has emerged as a novel mechanism in the progression of PD.
Targeting this mechanism could enable the development of disease-modifying therapies for patients with PD.
Nevertheless, the initial triggers of LB formation leading to acceleration of the process remain elusive.
MethodsTo evaluate α-syn function in viral replication, we infected coxsackievirus B3 (CVB3) to α-syn overexpressed neurons or α-syn transgenic (TG) mice.
We then performed biochemical and histological analyses to evaluate interaction between CVB3 and α-syn in Lewy body formation.
ResultsWe demonstrated that CVB3 infection can induce α-syn-associated inclusion body formation in neurons as a trigger.
The inclusion bodies contained clustered organelles, including damaged mitochondria with α-syn fibrils.
α-Syn overexpression accelerated inclusion body formation and induced more concentric inclusion bodies.
In brains from CVB3 infected mice, α-syn aggregates in the cell body of midbrain neurons were observed.
Additionally, α-syn overexpression favored CVB3 replication and related cytotoxicity.
α-Syn transgenic mice had a low survival rate, enhanced CVB3 replication, and further neuronal cell death, including dopaminergic neurons in the substantia nigra.
These results may be due to the different usage of autophagy between CVB3 and α-syn.
ConclusionsThis study elucidated the mechanism of Lewy body formation and the pathogenesis of PD associated with CVB3 infection.
Related Results
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009
Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009
Abstract
Previously, we explored the epidemic pattern and molecular characterization of enteroviruses isolated in Chungnam, Korea from 2005 to 2006. The present study ext...
Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization
Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization
AbstractAccumulation of α-synuclein aggregates in the substantia nigra pars compacta is central in the pathophysiology of Parkinson’s disease, leading to the degeneration of dopami...
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
AbstractBackgroundNNI‐362 is a novel small molecule identified by phenotypic screening to discover compounds that promote new neurons from human neural progenitor cells and have ne...
CNTNAP4 partial deficiency exacerbates α -synuclein pathology through astrocyte–microglia interplay
CNTNAP4 partial deficiency exacerbates α -synuclein pathology through astrocyte–microglia interplay
Abstract
BackgroundParkinson’s disease (PD) is a common progressive neurodegenerative movement disorder, which is characterized by dopaminergic (DA) neuron death and the ag...
Tuning Hsp104 specificity to selectively detoxify α-synuclein
Tuning Hsp104 specificity to selectively detoxify α-synuclein
SummaryHsp104 is an AAA+ protein disaggregase that solubilizes and reactivates proteins trapped in aggregated states. We have engineered potentiated Hsp104 variants to mitigate tox...
Association Between Serum Uric Acid Level and the Severity of Parkinsons Disease: A cross sectional study
Association Between Serum Uric Acid Level and the Severity of Parkinsons Disease: A cross sectional study
Background: Parkinson’s disease is a chronic, progressive, neurodegenerative disease. Various factors have been attributed to the development and progression of the diseaseover the...
ATP6V0A1 protects dopaminergic neurons via the autophagy-lysosomal pathway in Parkinson’s disease
ATP6V0A1 protects dopaminergic neurons via the autophagy-lysosomal pathway in Parkinson’s disease
Abstract
Parkinson’s disease is the second most common neurodegenerative disorder. ATPase H+ transporting V0 subunit A1 (ATP6V0A1) is a component of vacuolar H+-ATPase (V...

